Drug Type Small molecule drug |
Synonyms EMD 503982 |
Target |
Action inhibitors |
Mechanism factor Xa inhibitors(Factor Xa inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H23ClN4O5 |
InChIKeyDMYZJLOWGSRVKP-RTBURBONSA-N |
CAS Registry768370-75-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Arterial thrombosis | Phase 1 | United States | - | - |
| Thrombosis | Phase 1 | - | - | |
| Venous Thrombosis | Phase 1 | United States | - | - |





